Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

315 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pretreatment Hemoglobin Levels and Platelet-to-Lymphocyte Ratio Predict Survival Benefit from Pembrolizumab in Advanced Urothelial Carcinoma.
Kurashina R, Ando K, Inoue M, Maruyama R, Mitani K, Takenobu H, Haruta M, Onuki R, Matsuoka Y, Kamijo T, Kageyama Y. Kurashina R, et al. Among authors: kamijo t. Cancer Diagn Progn. 2023 Mar 3;3(2):230-235. doi: 10.21873/cdp.10206. eCollection 2023 Mar-Apr. Cancer Diagn Progn. 2023. PMID: 36875313 Free PMC article.
Positive regulatory loop of platelet-derived growth factor DD-induced STAT3 activation is associated with poor prognosis in advanced urothelial carcinoma.
Ando K, Kurashina R, Motoi N, Iizuka T, Inoue M, Maruyama R, Mitani K, Takenobu H, Haruta M, Onuki R, Matsuoka Y, Kamijo T, Kageyama Y. Ando K, et al. Among authors: kamijo t. Biochem Biophys Res Commun. 2023 Oct 8;676:165-170. doi: 10.1016/j.bbrc.2023.07.054. Epub 2023 Jul 26. Biochem Biophys Res Commun. 2023. PMID: 37517219 Free article.
Pediatric Precision Medicine at the National Cancer Center Japan: Prospective Genomic Study of Pediatric Patients with Cancer as Part of the TOP-GEAR Project.
Tao K, Yamazaki F, Kubo T, Sunami K, Kumamoto T, Arakawa A, Sugiyama M, Watanabe Y, Nakajima M, Shirakawa N, Tanimura K, Koyama T, Hirata M, Sudo K, Tanabe N, Watanabe T, Yoshida T, Kitami M, Yoshida A, Yatabe Y, Nakano Y, Ohira M, Kamijo T, Nakazawa A, Kato M, Ichimura K, Kohno T, Yamamoto N, Hishiki T, Ichikawa H, Ogawa C. Tao K, et al. Among authors: kamijo t. JCO Precis Oncol. 2023 Jul;7:e2200266. doi: 10.1200/PO.22.00266. JCO Precis Oncol. 2023. PMID: 37410973
Establishment and characterization of a novel MDM2/MYCN-co-amplified neuroblastoma cell line, NBN-SHIM, established from a late recurrent stage MS tumor.
Kato K, Nagai JI, Goto H, Shinkai M, Kitagawa N, Toyoda Y, Nishi T, Kigasawa H, Tanaka M, Kurosawa K, Ito Y, Haruta M, Kamijo T, Yoshimi A, Tsuchida M, Nagahara N, Tanaka Y. Kato K, et al. Among authors: kamijo t. Hum Cell. 2024 Sep;37(5):1602-1609. doi: 10.1007/s13577-024-01106-6. Epub 2024 Jul 30. Hum Cell. 2024. PMID: 39080217
315 results